IRIS
DI SARNO, ANTONELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.066
AS - Asia 1.046
EU - Europa 910
SA - Sud America 180
AF - Africa 30
Totale 3.232
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.022
SG - Singapore 612
RU - Federazione Russa 524
CN - Cina 233
BR - Brasile 136
HK - Hong Kong 86
DE - Germania 70
NL - Olanda 63
VN - Vietnam 60
IT - Italia 57
FI - Finlandia 50
IE - Irlanda 36
SE - Svezia 32
GB - Regno Unito 26
CA - Canada 23
AR - Argentina 18
MX - Messico 17
UA - Ucraina 16
IN - India 12
ZA - Sudafrica 11
EC - Ecuador 9
PL - Polonia 9
TR - Turchia 8
CI - Costa d'Avorio 7
CO - Colombia 6
IQ - Iraq 6
ES - Italia 5
FR - Francia 5
ID - Indonesia 5
JP - Giappone 5
PK - Pakistan 5
CL - Cile 4
AT - Austria 3
BD - Bangladesh 3
CZ - Repubblica Ceca 3
EG - Egitto 3
IL - Israele 3
LT - Lituania 3
MA - Marocco 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
EE - Estonia 2
TN - Tunisia 2
UZ - Uzbekistan 2
AD - Andorra 1
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
CG - Congo 1
CM - Camerun 1
CR - Costa Rica 1
DK - Danimarca 1
GY - Guiana 1
IS - Islanda 1
KE - Kenya 1
LV - Lettonia 1
MW - Malawi 1
MY - Malesia 1
NO - Norvegia 1
PE - Perù 1
TJ - Tagikistan 1
TL - Timor Orientale 1
Totale 3.232
Salva come PNG Salva come JPEG
Città #
Singapore 288
Chandler 178
Moscow 101
Hong Kong 86
Beijing 72
Ashburn 71
Amsterdam 59
Millbury 56
Jacksonville 42
Nanjing 42
San Jose 41
Princeton 35
Santa Clara 35
Los Angeles 33
Ho Chi Minh City 26
Wilmington 24
Munich 20
New York 19
São Paulo 19
The Dalles 18
Buffalo 13
Naples 13
Nanchang 12
Redondo Beach 12
Ann Arbor 11
Norwalk 11
Mexico City 10
Helsinki 9
Montreal 9
Warsaw 9
Boston 8
Turku 8
Chennai 7
Dallas 7
Ottawa 7
Shenyang 7
Brooklyn 6
Chicago 6
Denver 6
Hanoi 6
Rio de Janeiro 6
Seattle 6
Belo Horizonte 5
Houston 5
Kunming 5
London 5
Milan 5
Phoenix 5
Tianjin 5
Tokyo 5
Brasília 4
Changsha 4
Da Nang 4
Erbil 4
Falkenstein 4
Guangzhou 4
Haiphong 4
Jiaxing 4
Johannesburg 4
Ningbo 4
Orem 4
Quito 4
San Francisco 4
Toronto 4
Camaçari 3
Des Moines 3
Düsseldorf 3
Hebei 3
Jinan 3
Lahore 3
Manchester 3
Pune 3
Querétaro 3
Recife 3
San Sebastiano al Vesuvio 3
Secaucus 3
Tel Aviv 3
Torino 3
Atlanta 2
Banhā 2
Bari 2
Boardman 2
Brno 2
Canoas 2
Cape Town 2
Curitiba 2
Dearborn 2
Harbin 2
Hefei 2
Hải Dương 2
Itapira 2
Itaquaquecetuba 2
Jakarta 2
Kronberg 2
La Paz 2
Las Vegas 2
Moreno 2
Napoli 2
Nuremberg 2
Poplar 2
Totale 1.636
Salva come PNG Salva come JPEG
Nome #
Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males 135
Hepatic arterial embolization in patients with neuroendocrine tumors. 131
Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors 121
The treatment with cabergoline for 24 month normalizes the quality of seminal fluid in hyperprolactinaemic males. 120
Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patients 116
Prolactinomas in children and adolescents. Clinical presentation and long-term follow-up 115
Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives 112
Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: a comparison with bromocriptine 111
Prolactin and prostate hypertrophy: a pilot observational, prospective, case-control study in men with prolactinoma 109
Short-term suppression of GH and IGF-I levels improves gonadal function and sperm parameters in men with acromegaly 108
Prediction of efficacy of octreotide therapy in patients with acromegaly 106
An evaluation of patients with hyperprolactinemia: have dynamic tests had their day? 105
Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1 101
Cabergoline-induced CSF rhinorrhea in patients with macroprolactinoma. Report of three cases 100
Corticotropin-releasing hormone administration increases alpha-melanocyte-stimulating hormone levels in the inferior petrosal sinuses in a subset of patients with Cushing's disease 98
CV 205-502 treatment in therapy-resistant acromegalic patients 97
Role of contrast-enhanced ultrasound to define prognosis and predict response to biotherapy in pancreatic neuroendocrine tumors 97
Chronic treatment with CV 205-502 restores the gonadal function in hyperprolactinemic males 95
Effects of a chronic treatment with octreotide in patients with functionless pituitary adenomas 94
Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment 92
Hyperprolactinemia in men: clinical and biochemical features and response to treatment 90
Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia 89
Effect of different dopaminergic agents in the treatment of acromegaly 87
Comparison among different dopamine-agonists of new formulation in the clinical management of macroprolactinomas 85
Corticotropin-releasing hormone test: improvement of the diagnostic accuracy of simultaneous and bilateral inferior petrosal sinus sampling in patients with Cushing syndrome 84
Usefulness of CV 205-502 in a case of allergy to ergot-derived drugs. 83
Power Doppler improves the diagnostic accuracy of color Doppler ultrasonography in cold thyroid nodules: follow-up results 82
Vasopressin levels in Cushing's disease: inferior petrosal sinus assay, response to corticotrophin-releasing hormone and comparison with patients without Cushing's disease 69
Prostatic hyperplasia: an unknown feature of acromegaly 68
Simultaneous and bilateral inferior petrosal sinus sampling for the diagnosis of Cushing's syndrome: comparison of multihormonal assay, baseline multiple sampling and ACTH-releasing hormone test 65
Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly 65
Effects of a chronic treatment with octreotide in patients with functionless pituitary adenomas. 63
Increased prevalence of tricuspid regurgitation in patients with prolactinomas chronically treated with cabergoline 63
Evolution of an aggressive prolactinoma into a growth hormone secreting pituitarytumor coincident with GNAS gene mutation. 58
Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage 55
Totale 3.269
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.168
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.168
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202120 0 0 0 0 0 0 3 0 5 3 5 4
2021/2022226 1 0 0 1 5 22 2 6 38 26 40 85
2022/2023378 37 37 16 33 46 39 1 34 52 64 11 8
2023/2024133 9 32 18 7 2 8 6 13 0 1 19 18
2024/20251.013 42 29 1 10 19 52 124 72 47 105 432 80
2025/20261.204 217 99 172 180 401 83 52 0 0 0 0 0
Totale 3.269